We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$219M
Cap. Flow %
-31.89%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Technology 5.89%
3 Financials 5.84%
4 Consumer Discretionary 1.07%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$58.3M 8.47%
1,227
+477
+64% +$219K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.5B
$45.3M 6.59%
2,037
+243
+14% +$51.5K
GILD icon
3
CALL
Gilead Sciences
GILD
$165B
$39.9M 5.79%
+5,489
New +$378K
BTBT icon
4
Bit Digital
BTBT
$428M
$25.6M 3.73%
4,215,852
-458
-0% -$4.38K
SRNE
5
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$13.2M 1.92%
21,897
+51
+0.2% +$317
VXX icon
6
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$169M
$12.9M 1.88%
436
+102
+31% +$36.2K
SLAI
7
DELISTED
SOLAI Ltd ADS
SLAI
$12.3M 1.79%
28,571
OEF icon
8
CALL
iShares S&P 100 ETF
OEF
$19.5B
$11.7M 1.71%
528
-972
-65% -$206K
AIOS
9
AIOS Tech
AIOS
$41.8M
$10.4M 1.51%
+16,134
New +$28.5M
SRNE
10
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$10.2M 1.48%
2,189,700
+491,593
+29% +$3.05M
REW icon
11
PUT
Proshares UltraShort Technology
REW
$3.85M
$9.06M 1.32%
+196
New +$23.2K
ROI
12
DELISTED
RiskOn International, Inc. Common Stock
ROI
$7.16M 1.04%
1,070
+583
+120% +$61.8K
XNTK icon
13
PUT
State Street SPDR NYSE Technology ETF
XNTK
$1.94B
$7.03M 1.02%
628
-1,085
-63% -$180K
BTBT icon
14
PUT
Bit Digital
BTBT
$428M
$6.68M 0.97%
10,983
+5,397
+97% +$51.6K
MARA icon
15
PUT
Marathon Digital Holdings
MARA
$3.83B
$6.56M 0.95%
1,997
+12
+0.6% +$574
CAN
16
PUT
Canaan Creative
CAN
$172M
$5.49M 0.8%
10,662
+2,787
+35% +$21K
DJT icon
17
PUT
Trump Media & Technology Group
DJT
$2.73B
$5.03M 0.73%
+978
New +$44.2K
RIOT icon
18
PUT
Riot Platforms
RIOT
$6.9B
$4.88M 0.71%
2,183
+1,164
+114% +$34.7K
ESPR
19
DELISTED
Esperion Therapeutics
ESPR
$4.7M 0.68%
+940,400
New +$7.53M
VXX icon
20
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$169M
$4.63M 0.67%
15,625
-9,375
-38% -$3.33M
SWAG icon
21
Stran & Co
SWAG
$38M
$4.54M 0.66%
+750,000
New +$3.79M
RIOT icon
22
Riot Platforms
RIOT
$6.9B
$4.45M 0.65%
199,064
+118,012
+146% +$3.51M
HMCO
23
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$3.95M 0.57%
404,185
COCP icon
24
Cocrystal Pharma
COCP
$12M
$3.73M 0.54%
478,177
+47,726
+11% +$488K
AGMH icon
25
AGM Group Holdings
AGMH
$1.67M
$3.58M 0.52%
+29,869
New +$13.2M

Similar funds

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $219M in Q4 2021, closing 44 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 6.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 44 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.